Current Issue
Subscribe
CDC urges baby boomer testing; new drugs in development.
The release of two new oral medications marks another significant advance in the fight against hepatitis C.
Boceprevir and telaprevir were approved for treatment of hepatitis C in May 2011.
2,500
people attend the NHF Annual Meeting each fall.
